Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2010
08/24/2010US7781431 Thienopyrroles as antiviral agents
08/24/2010US7781430 Benzoxazole carboxamides for treating CINV and IBS-D
08/24/2010US7781426 cholesterol ester transfer protein (CETP) inhibitors such as (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[2-(3,3-dimethylpiperidin-1-yl)-5-(trifluoromethyl)benzyl]-4-methyl-1,3-oxazolidin-2-one, useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis
08/24/2010CA2460135C Use of pyridazinone compounds as phosphodiesterase iv inhibitors for treating cancer and other diseases
08/19/2010WO2010093595A1 Fungicidal 2-pyridones
08/19/2010WO2010093419A1 Novel amino azaheterocyclic carboxamides
08/19/2010WO2010093061A1 Diazepinedione derivative
08/19/2010WO2010092966A1 Novel triazine derivative and pharmaceutical composition containing same
08/19/2010WO2010092962A1 Hetero ring derivative
08/19/2010WO2010092660A1 Inhibitor of casein kinase 1δ and casein kinase 1ε
08/19/2010WO2010091721A1 3 -substituted 1-arylsulfonylpiperidine derivatives for the treatment of pain
08/19/2010WO2010074607A3 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
08/19/2010WO2010039534A3 Viral and fungal inhibitors
08/19/2010WO2009122034A8 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
08/19/2010US20100210849 Compositions and Methods for Controlling Nematodes
08/19/2010US20100210845 process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/19/2010US20100210837 Pactamycin biosynthetic gene cluster
08/19/2010US20100210836 Small molecule inhibitors of lymphoid tyrosine phosphatase
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210660 Heterocyclic FXR Binding Compounds
08/19/2010US20100210651 Isoxazole-isoxazoles and isoxazole-isothiazoles
08/19/2010US20100210649 Pyridazinones and furan-containing compounds
08/19/2010US20100210648 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
08/19/2010US20100210647 Indole compounds as an inhibitor of cellular necrosis
08/19/2010US20100210646 2-morpholin-4-yl-pyrimidines as pi3k inhibitors
08/19/2010US20100210644 Chemical compounds
08/19/2010US20100210642 Acetylenyl-pyrazolo-pyrimidine derivatives
08/19/2010US20100210640 Benzamide derivatives, their preparation and uses in medicine thereof
08/19/2010US20100210639 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h 1,3,6,9 tetraaza-fluorenes as chk1 kinase function inhibitors
08/19/2010US20100210637 Heteroaryloxy nitrogenous saturated heterocyclic derivative
08/19/2010US20100210636 Benzoxazinone derivative
08/19/2010US20100210635 Renin inhibitors
08/19/2010US20100210634 Certain Chemical Entities, Compositions and Methods
08/19/2010US20100210633 Carboxamide compounds and their use
08/19/2010US20100210632 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
08/19/2010US20100210630 Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase
08/19/2010US20100210629 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
08/19/2010US20100210628 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210627 Pyrazine compounds, their use and methods of preparation
08/19/2010US20100210619 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis
08/19/2010US20100210618 Piperidine/piperazine derivatives
08/19/2010US20100210617 Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase Inhibitors
08/19/2010US20100210610 Organic compounds
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/19/2010US20100210593 Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
08/19/2010US20100210592 Amines or amino alcohols as glyt1 inhibitors
08/19/2010US20100210036 Ppar active compounds
08/19/2010US20100209488 Protein kinase modulating compounds and methods for making and using them
08/19/2010US20100207517 Oxadiazole Derivative, and Light-Emitting Element and Light-Emitting Device Using Oxadiazole Derivative
08/19/2010CA2789641A1 Diazepinedione derivative
08/19/2010CA2755935A1 Hetero ring derivative
08/19/2010CA2752269A1 Novel triazine derivative and pharmaceutical composition comprising the same
08/19/2010CA2752190A1 Small molecule bradykinin b1 receptor antagonists
08/19/2010CA2751886A1 Novel amino azaheterocyclic carboxamides
08/18/2010EP2218720A1 2-2'-Bis-thiazole derivatives as antiviral agents
08/18/2010EP2217594A2 Novel pyrimidine derivatives
08/18/2010EP2217592A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto
08/18/2010EP2217589A2 Modulators of ocular oxidative stress
08/18/2010EP2217588A1 Inhibitors of histone deacetylase
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010EP1934203B1 3,4-dihydro-2H-benzo[1,4]oxazine and 3,4-dihydro-2H-benzo[1,4]thiazine COMPOUNDS AS ALPHA2C ADRENORECEPTOR AGONISTS
08/18/2010EP1758857B1 Indole derivatives as antiviral agents
08/18/2010EP1682523B1 Morpholine derivatives as norepinephrine reuptake inhibitors
08/18/2010EP1631561B1 Compositions and methods for non-invasive imaging of soluble beta-amyloid
08/18/2010EP1578423B1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010CN1993352B Piperazine derivatives with CCR3 inhibiting activity
08/18/2010CN1795193B N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors
08/18/2010CN101809099A New organic fluorescent sulfonyl ureido benzoxazinone pigments
08/18/2010CN101809019A Gamma secretase modulators
08/18/2010CN101809013A herbicide triazolylpyridine ketones
08/18/2010CN101809006A Method of producing benzoxazinone-based compound
08/18/2010CN101809005A Fused bicyclic compound
08/18/2010CN101808999A Quinoline derivatives as 5HT5A receptor antagonists
08/18/2010CN101808988A Piperidine and piperazine derivatives
08/18/2010CN101808693A Triazine kinase inhibitors
08/18/2010CN101808646A Agent for improving motor complications or psychiatric symptoms in parkinson's disease
08/18/2010CN101805338A Oxadiazole-based piperazine derivative and application thereof
08/18/2010CN101805337A Compound containing proline and isoxazole skeleton and preparation method and application thereof
08/18/2010CN101805336A Compound containing tryptophane and isoxazole skeleton and preparation method and application thereof
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/18/2010CN101160128B Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
08/18/2010CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
08/17/2010US7777069 Prodrugs of carbamate inhibitors of IMPDH
08/17/2010US7777057 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/17/2010US7777051 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7777048 Reacting an organic amine compound with a carbamyl-group-containing amide compound in the presence of a suitable polar or nonpolar aprotic, substantially anhydrous solvent or mixtures thereof; used as therapeutic agents for inosine-5*-monophosphatedehydrogenase (IMPDH)-mediated diseases
08/17/2010US7777036 1'-(2-Trifluoromethylbenzoyl)-1',2',3',6'-tetrahydro-[2,4']bipyridinyl-5-carboxylic acid (2-cyclopropylethyl)amide; for diseases mediated by stearoyl-CoA desaturase enzymes, preferably SCD1, especially those related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome
08/17/2010US7777032 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
08/17/2010US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
08/17/2010US7776885 Benzimidazolone compounds having 5-HT4 receptor agonistic activity
08/17/2010US7776876 administering cyclic Glycyl-2-Allyl Proline as as neuroprotectants, for the prophylaxis of nervous system disorders
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/17/2010US7776861 Cycloheteroalkenyl compounds used as analgesics and for treating incontinence, inflammatory bowel disease, Parkinson's disease, amyotrophic lateral sclerosis, dementia, epilepsy, retinopathy, pruritus, psychoses, Huntington's disease, headaches, vomiting, dyskinesia or as anxiolytics and antidepressants
08/17/2010US7776856 Fused pyrimidines such as 2-(1H-Indol -4-yl )-6-(4-methyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine, uses as phosphatidylinositol 3-kinase inhibitors, for the treatment of cancer, viral infection, inflammation, metabolic, endocrine, immune and cardiovascular disorders
08/17/2010US7776855 Antimicrobial oxazolidinone prodrugs
08/17/2010US7776853 Dietetics therapy; lipase inhibitor
08/17/2010US7776545 Detection of toxic gluten oligopeptides refractory to digestion by using antibodies and T cells responsive thereto; producing the antibodies by immunization of an animal